SARS‐CoV‐2 neutralizing antibodies decline over one year and patients with severe COVID‐19 pneumonia display a unique cytokine profile

SARS‐CoV‐2 neutralizing antibodies decline over one year and patients with severe COVID‐19 pneumonia display a unique cytokine profile

Objectives: As coronavirus disease 2019 (COVID-19) rages on worldwide, there is an urgent need to characterize immune correlates of protection from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and to identify immune determinants of COVID-19 severity. Methods: This study exa...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Vimvara Vacharathit, Sirawat Srichatrapimuk, Suwimon Manopwisedjaroen, Suppachok Kirdlarp, Chanya Srisaowakarn, Chavachol Setthaudom, Nanthicha Inrueangsri, Prapaporn Pisitkun, Mongkol Kunakorn, Suradej Hongeng, Somnuek Sungkanuparph, Arunee Thitithanyanont
Formato: article
Lenguaje:EN
Publicado: Elsevier 2021
Materias:
SARS-CoV-2
COVID-19 disease severity
Neutralizing antibodies
Neutralization kinetics
Cytokines
Cytokine storm
Infectious and parasitic diseases
RC109-216
Acceso en línea:https://doaj.org/article/a00a1138c3ac4228a1bea8270b8ee403
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

https://doaj.org/article/a00a1138c3ac4228a1bea8270b8ee403

Ejemplares similares